We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Global Swab and Viral Transport Medium Market Growing Rapidly Due to Rising Demand from COVID-19 Pandemic

By LabMedica International staff writers
Posted on 14 Sep 2020
The global swab and viral transport medium market (VTM) was valued at USD 0.9 billion in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030 to reach USD 2.2 billion by 2030, driven by increased demand during the COVID-19 (coronavirus) pandemic.

Since research institutes and labs have intensified their experiments for developing COVID-19 vaccines, companies in the swab and VTM market have increased their production capacities to develop products useful for viral collection, maintenance, and culture. More...
Rapid antigen testing and molecular assay experiments have fueled the demand for swab and VTM during the ongoing coronavirus crisis. Long-term freezers and direct fluorescent antibody (DVA) applications are creating incremental opportunities for companies in the swab and VTM market.

These are the findings of Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider.

VTM enables safe transfer of viruses, chlamydia, and mycoplasma for research, including conventional cell culture methods, diagnostic tests, and molecular biology techniques. Swabs collected and transported dry or in saline are compared to commercially available swab/medium combinations for PCR detection of influenza, enterovirus, herpes simplex virus, and adenovirus. In terms of product, the transport medium segment accounted for a major share of the global swab and VTM market in 2019. The transport medium segment is anticipated to expand at a high CAGR during the forecast period, owing to rise in the need and demand for detection and prevention of the infectious diseases across the world. Based on application, the viral infection diagnosis segment held a significant share of the global swab and VTM market in 2019.

Geographically, North America accounted for a significant share of the global swab and VTM market in 2019. The presence of key players and growth strategies adopted by these players are the major factors driving the swab and VTM in the region. Rise in awareness about the benefits of prevention of diseases and increase in healthcare expenditure augment the swab and VTM market in North America. Asia Pacific held the second-largest share of the global swab and VTM market in 2019. The growth of the swab and VTM market in the region can be attributed to rise in prevalence of infectious diseases. The market in Asia Pacific is likely to grow at a rapid pace during the forecast period. The development of vaccines and other pharma products to cope with diseases and rise in awareness leading to routine check-up and diagnosis are the major factors anticipated to fuel the growth of the swab and VTM market in the region.

Companies in the swab and VTM market are innovating in kits containing vials, double-ended flocked swabs, antibiotics, and other items that inhibit bacterial or fungal contamination. They are focusing on improved formulation of Hanks solution to contain the reproduction of bacterial and fungal flora. Innovative VTM products are bolstering market growth. Manufacturers in the swab and VTM market are innovating in products that facilitate rapid antigen testing, viral culture, and molecular-based assay. They are adopting the vertically integrated approach to manufacture swab and VTM in order to gain complete control over the entire process.

3 dimensional (3D) printers are being used to produce cost-efficient nasopharyngeal swabs. Companies in the swab and VTM market are using fused deposition modelling (FDM) printers to manufacture nasopharyngeal swab in a cost-efficient manner. Manufacturers are using FDA-approved biocompatible materials in swab such as polylactic acid (PLA) plastic filament. They are making use of renewable resources such as sugarcane and tapioca roots to produce 3D printed swab. On the other hand, companies are using flocking methods to electrostatically deposit small fibers of synthetic materials onto an adhesive-coated surface to produce nasopharyngeal swabs. In order to eliminate the need for adhesives, manufacturers are using mini blunt-ended hooks to secure polyester threads of nasopharyngeal swabs.

Related Links:
Transparency Market Research


Gold Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Collection and Transport System
PurSafe Plus®
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.